Weill Medical College of Cornell University: Alzheimer Disease trials

The registry lists 12 Alzheimer Disease studies with Weill Medical College of Cornell University as lead sponsor. 4 are open to participants now and 2 have results posted.

Phase 2 5Phase 4 1No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's DiseaseRecruitingNCT07553338Phase 2
• Pilot Study of StudyU for N-of-1 Trials in HFrEF Patients (N-of-1 App)Enrolling by invitationNCT07252310Phase 4
• Evaluating the Efficacy of the Pain Identification and Communication ToolkitRecruitingNCT06168604Not applicable
• The Comparative Effectiveness Dementia & Alzheimer's RegistryEnrolling by invitationNCT03687710
• A Non-pharmacological Intervention for Patients With Alzheimer's Disease and Family Caregivers (Care Partners Program)CompletedNCT03333252Not applicableResults posted
• Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's DiseaseTerminatedNCT00299988Phase 2Results posted
• A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)Active, not recruitingNCT06223360Phase 2
• Developing a Communication Intervention for People With Memory Challenges and Their Care PartnersCompletedNCT05143255Not applicable
• Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to DaratumumabActive, not recruitingNCT04270175Phase 2
• PET Measures of CSF Clearance in Preclinical Alzheimer's DiseaseCompletedNCT03663387
• The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer'sCompletedNCT03649724Phase 2
• Effectiveness of Alzheimer's Universe (Www.AlzU.Org) on Knowledge and BehaviorWithdrawnNCT03149380Not applicable